Related Experiment Video
Updated: Jul 31, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Global coagulation assays in patients with chronic kidney disease and their role in predicting thrombotic risk
Hui Yin Lim1, Brandon Lui2, Mark Tacey3
1Northern Clinical Pathology, Thrombosis & Radiology (NECTAR) Research Group, Northern Pathology Victoria, Northern Health, Epping, VIC, Australia; Department of Medicine, University of Melbourne, Northern Health, Epping, VIC, Australia; Department of Medicine, University of Melbourne, Austin Health, Heidelberg, VIC, Australia; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia.
Insights
Patients with chronic kidney disease (CKD) exhibit a hypercoagulable state, increasing thrombotic risk. Global coagulation assays identified key predictors like tissue factor pathway inhibitor (TFPI) for better risk assessment in CKD patients.
Area of Science:
- Nephrology
- Hematology
- Cardiovascular Medicine
Background:
- Cardiovascular diseases and thrombosis are leading causes of mortality in chronic kidney disease (CKD) patients.
- Currently, effective biomarkers for predicting thrombotic risk in CKD are lacking.
Purpose of the Study:
- To evaluate global coagulation assays in CKD patients.
- To correlate coagulation biomarkers with clinical outcomes in CKD.
Main Methods:
- Prospective observational study of 90 CKD patients (eGFR<30 mL/min/1.73m²).
- Global coagulation assays performed: thromboelastography, calibrated automated thrombogram (CAT), overall hemostatic potential (OHP), and tissue factor pathway inhibitor (TFPI).
Main Results:
- CKD patients showed hypercoagulable states compared to controls (increased thromboelastography amplitude, peak thrombin, OHP, and TFPI).
- Peritoneal-dialysis patients exhibited more hypercoagulable parameters than hemodialysis patients.
- Key predictors of thrombotic complications included dialysis, higher fibrinogen, reduced endogenous thrombin potential, elevated D-dimer, and increased TFPI.
Conclusions:
- CKD confers a hypercoagulable state, increasing thrombotic risk.
- Paradoxical association of reduced thrombin generation and raised TFPI with thrombotic risk suggests complex compensatory mechanisms.
- Developed risk model outperformed existing scores for predicting clinical outcomes in dialysis patients.
Background:
Despite cardiovascular diseases and thrombosis being major causes of death in patients with chronic kidney disease (CKD), there remains no effective biomarker to predict thrombotic risk in this population.
Objective:
To evaluate global coagulation assays in patients with CKD and correlate the biomarkers to clinical outcomes.
Material And Methods:
Patients with eGFR<30 mL/min/1.73m2 were recruited (n = 90) in this prospective observational study. Blood samples were collected for global coagulation assays, including thromboelastography, calibrated automated thrombogram (CAT), overall hemostatic potential (OHP) and tissue factor pathway inhibitor (TFPI).
Results:
Following adjustment for age and gender, CKD subjects (mean age 66 years, 36 % female) had increased maximum amplitude on thromboelastography (70.1 vs 60.2 mm, p < 0.001), higher peak thrombin (233.2 vs 219.7 mm, p = 0.030) and increased OHP (16.1 vs 6.4 units, p < 0.001) compared to healthy controls (n = 153). TFPI was also increased in CKD patients (36.4 vs 14.5 ng/mL, p < 0.001). Compared to hemodialysis patients (n = 43), peritoneal-dialysis patients (n = 25) had more hypercoagulable parameters. Thirty-five CKD patients reported thrombotic complications - key predictors included dialysis, higher fibrinogen, reduced endogenous thrombin potential, elevated D-dimer and increased TFPI. Using the dialysis cohort, the predictive risk model based on the key predictors performed better than Framingham heart score and number of cardiovascular risk factors (Harrell's C-stat 0.862 vs 0.585 vs 0.565).
Conclusion:
CKD appears to confer a hypercoagulable state compared to healthy controls. Interestingly, reduced thrombin generation and raised TFPI was paradoxically associated with increased thrombotic risks, highlighting possible complex compensatory mechanisms within the coagulation system, which may be important in predicting clinical outcomes.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction

